The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
MicroRNAs and response to anti-EGFR therapy in metastatic colorectal cancer.
Moisés Blanco-Calvo
No relevant relationships to disclose
Mar Haz-Conde
No relevant relationships to disclose
Teresa Rodríguez-Rigueiro
No relevant relationships to disclose
Angelica Figueroa
No relevant relationships to disclose
Margarita Reboredo
No relevant relationships to disclose
Vanessa Medina Villaamil
No relevant relationships to disclose
Maria J Lorenzo-Patiño
No relevant relationships to disclose
Francisco Arnal
No relevant relationships to disclose
Luis Antón-Aparicio
No relevant relationships to disclose
Guillermo Alonso-Jaudenes Curbera
No relevant relationships to disclose
Manuel Valladares-Ayerbes
Consultant or Advisory Role - Amgen; Merck Serono
Research Funding - Amgen (B); Merck Serono